1Y Close · As of Aug 26, 2026
MedPacto operates in the Professional Services sector.
Legal name: MedPacto, Inc.
In fiscal year 2025, MedPacto (235980) reported revenue of 3.9 billion KRW.
Operating profit was -14.0 billion KRW and net income was -12.8 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 94.8 billion KRW, with a P/B of 2.06.
These figures can be verified in the DART filing (receipt no. 20260318001008).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 3.9B | -14.0B | -12.8B |
| 2024 | — | -21.8B | -20.1B |
| 2023 | — | -28.8B | -35.3B |
Recent Filings
Semi-Annual Report (2026.06)
Material Business Matters (Clinical Trial Amendment Application)
Checks
1 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-13 | Semi-Annual Report (2026.06) |
| 2026-08-07 | Material Business Matters (Clinical Trial Amendment Application) |